CancerX Startup Accelerator

in partnership with

MassChallenge

CancerX is thrilled to announce the 16 startup companies selected for the first cohort of our Accelerator program! This group was selected from a robust list of more than 100 applicants who shared their ideas for digital innovation – in the areas of clinical research; screening and diagnosis; treatment and management; clinical operations; or patient, caregiver, and survivor experience – aiming to reduce the burden of cancer for all people.

Xanthos

Accelerator Cohort 2024

Learn more about the 16 Accelerator Startups and more than 100 Mentors who will work together to test and validate new innovative solutions.

CancerX is proud to recognize the generous contribution of our Platinum Champions and Gold Champions. Thank you for your support and investment in digital innovations that aim to reduce the burden of cancer for all people.

Platinum Champions

Debiopharm Innovation Fund logo
MassChallenge
Reveal Prism

Gold Champions

AstraZeneca
Atrium-Health-UPDATED.png
AWS
DellTech_Logo_Prm_Blue_Gry_rgb
Intel
Oncology Ventures
UC Davis Health

More About CancerX Accelerator

CancerX Accelerator is the first-ever innovation accelerator to focus at the intersection of digital innovation and cancer. It uniquely brings together a community of champions, innovators, and users of digital health in oncology to generate and scale ideas that have the potential to solve unmet needs in clinical delivery for cancer patients and providers.

Every fall, submissions open for the next Accelerator cohort, and a panel of esteemed CancerX Champions and judges conduct several rounds of judging during winter to select the startup finalists.

Sign up to be the first to hear about details for Cohort 2025.